CARB-X supports BioVersys in the fight against antimicrobial resistance with up to almost 9 million dollars

BioVersys receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies:

https://www.b3cnewswire.com/201910291992/bioversys-receives-carb-x-award-of-up-to-us-8-92-million-for-development-of-novel-antimicrobial-therapies.html